Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of anti-CD137 antibody drug conjugate (ADC) in allogeneic cell therapy

Use of anti-CD137 antibody drug conjugate (ADC) in allogeneic cell therapy

US Patent 12403185 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating autoimmune diseases2025
Methods and compositions for treating autoimmune diseases2025
Anti-CD45 antibodies and conjugates thereof2025
Anti-CD45 antibodies and conjugates thereof2025
Compositions and methods for the depletion of CD5+ cells2025
Compositions and methods for the depletion of CD5+ cells2025
Anti-CD45 antibodies and conjugates thereof2025
Anti-CD45 antibodies and conjugates thereof2025
Antibody drug conjugates for ablating hematopoietic stem cells2024
Antibody drug conjugates for ablating hematopoietic stem cells2024
Use of anti-CD5 antibody drug conjugate (ADC) in allogeneic cell therapy2024
Use of anti-CD5 antibody drug conjugate (ADC) in allogeneic cell therapy2024